December 13, 2020 British pharmaceutical giant AstraZeneca said Friday it would soon start work with Russia’s Gamaleya Institute to investigate whether their two coronavirus vaccine candidates could be successfully combined.
It comes after the developers of the Sputnik V Covid-19 vaccine approached AstraZeneca via Twitter last month to ask if they should try combining both to boost vaccine efficacy.
“Being able to combine different COVID-19 vaccines may help improve protection and improve vaccine accessibility. This is why it is important to explore different vaccine combinations to help make immunization programs more flexible, by allowing physicians greater choice at the time of administering vaccines,” AstraZeneca said in a statement.
AstraZeneca’s Covid-19 vaccine, produced in collaboration with the University of Oxford, is one of several seeking to secure approval from medicine regulators amid rising hopes that a mass vaccination campaign could help end the pandemic.
To date, more than 69 million people have contracted the coronavirus worldwide, with 1.58 million related deaths, according to data compiled by Johns Hopkins University.
“We welcome the beginning of this new stage of cooperation between vaccine producers. We are determined to develop this partnership in the future and to start joint production after the new vaccine demonstrates its efficacy in the course of clinical trials,” Dmitriev said.
We provide the insights on leaders who are responsible for taking their organization to new heights, all the while bringing together a group of talented individuals.
U.S. Steel has announced the indefinite idling of primary operations at its Granite City, Illinois, facility, which is expected to result in significant …
Sembcorp Industries Ltd., a Singapore-based energy company, has acquired more than 200 MW of operational wind power assets from Leap Green …
The Trusts, a community-owned liquor monopoly in West Auckland, is facing a strategic review of its $40 million expansion …
Paycor’s human capital management (HCM) platform modernizes every aspect of people management, from recruiting, onboarding, and payroll to career development and retention, but what really sets us apart is our focus on leaders.
In today’s day and age, there are numerous reports of increasing anxiety levels, low motivation, and exhaustion. But have we ever thought that the people struggling with those problems are the same people showing up to work at various organizations? This is not about a few employees just having a bad day.
HiBob is at the forefront of HR innovation, transforming the way organizations operate in the modern world of work with its award-winning HCM ‘Bob’. Its modular approach caters to the needs of multinational companies seeking agile technology and robust analytics to support operations across distributed workforces in the ever-evolving economic and workplace landscape.